Torsemide

Basic Information

Product Name

Torsemide

FDA Product Code

62135-820

Regulatory Information

NDC Product Code

62135-820

Application Number

ANDA076894

Marketing Category

C73584

Effective Date

February 1, 2024

Territorial Authority

USA

FDA Title

Torsemide Tablets, USP These highlights do not include all the information needed to use TORSEMIDE TABLETS safely and effectively. See full prescribing information for TORSEMIDE TABLETS TORSEMIDE tablets, for oral use Initial U.S. Approval: 1993

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Version Number

Active Ingredients

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

CROSPOVIDONE, UNSPECIFIED

Code: 2S7830E561

Class Code: IACT

TORSEMIDE

Quantity: 20 mg in 1 1

Code: W31X2H97FB

Class Code: ACTIB

Active Moieties

Code: W31X2H97FB

Torsemide

Basic Information

Regulatory Information

Company Information

Active Ingredients

LACTOSE MONOHYDRATE

SILICON DIOXIDE

MAGNESIUM STEARATE

MICROCRYSTALLINE CELLULOSE

CROSPOVIDONE, UNSPECIFIED

Active Moieties

TORSEMIDE